Transplantation for primary biliary cirrhosis

Seminars in Liver Disease

Volumn 17, Issue 2, 1997, Pages 137-146

  Neuberger, James ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Liver transplantation; Primary biliary cirrhosis; Prognostic models; Recurrent disease

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; ANDROGEN; ANTIGEN; ANTIHISTAMINIC AGENT; AZATHIOPRINE; BILIRUBIN; COLESTIPOL; COLESTYRAMINE; CORTICOSTEROID; CYCLOSPORIN; DIURETIC AGENT; HLA ANTIGEN; IMMUNOGLOBULIN; MITOCHONDRION ANTIBODY; NALMEFENE; NALOXONE; NALTREXONE; ONDANSETRON; OXYGEN; PHENOBARBITAL; PRIMROSE OIL; PROPOFOL; RIFAMPICIN; STANOZOLOL; TACROLIMUS; UNINDEXED DRUG; UREA; URSODEOXYCHOLIC ACID; VITAMIN D;

ARTICLE; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; HEPATOPULMONARY SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LETHARGY; LIVER GRANULOMA; LIVER TOXICITY; LIVER TRANSPLANTATION; MALNUTRITION; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; PRURITUS; QUALITY OF LIFE; RECURRENT DISEASE; SURVIVAL;

EID: 0030992985     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007192     Document Type: Article

References (56)

1. European Liver Transplant Registry, Paris, 1996.
2. Swain M, Maric M: Defective corticotropin-releasing hormone mediated neuroendocrine and behavioural responses in cholestatic rats: implications for cholestatic liver disease-related sickness behaviours. Hepatology 22:1560-4, 1995.
3. Jones EA: Fatigue associated with chronic liver disease: a riddle wrapped in a mystery inside an enigma. Hepatology 22: 1606-8, 1995.
4. Turnberg LA, Mahoney M, Gleeson D, et al: Plasmaphoresis and plasma exchange in the treatment of hyperlipaemia and xanthomatous neuropathy in patients with primary biliary cirrhosis. Gut 13:976-81, 1972.
5. Poupon R, Poupon RE, Calmus Y, et al: Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1: 834-6, 1987.
6. Matsuzaki Y, Tanaka N, Osuka T, et al: Improvement of biliary enzyme levels and itching as a result of long-term administration or ursodeoxycholic acid in primary biliary cirrhosis. Am J Gastroenterol 85:15-23, 1990.
7. Bachs L, Pares A, Elena M, et al: Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet 1:574-6, 1989.
8. Bloomer JR, Boyer JL: Phenobarbital effects in cholestatic liver disease. Ann Intern Med 82:310-7, 1975.
9. Whitington P, Whittington GL: Partial external diversion for bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology 95:130-6, 1988.
10. Cerio R, Murphy G, Sladen G, MacDonald D: A combination of phototherapy and cholestyramine for the relief of pruritus in primary biliary cirrhosis. Br J Dermatol 116:265-7, 1987.
11. Walt R, Daneshmand T, Fellows I, Toghill P: Effect of stanozolol on itching in primary biliary cirrhosis. Br Med J 296:607, 1988.
12. Jones EA, Bergasa N. The pruritus of cholestasis: from bile acids to opiate agonists. Hepatology 11:884-7, 1990.
13. Bergasa N, Jones EA: The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids. Gastroenterology 108:1582-8, 1995.
14. Borgeat A, Wilder-Smith O, Mentha G: Subhypnotic doses of propofol relieve pruritus associated with liver disease. Gastroenterology 104:244-7, 1993.
15. Rosen H: Primary biliary cirrhosis and bone disease. Hepatology 21:253-5, 1995.
16. Hay JE, Dickson E, Wiesner R: Long-term effect of orthotopic liver transplantation on the osteopenia of primary biliary cirrhosis [abstract]. Hepatology 12:838, 1990.
17. Eriksson L, Soderman C, Ericzon B, et al: Normalization of ventilation/perfusion relationships after liver transplantation in patients with decompensated cirrhosis: evidence for a hepatopulmonary syndrome. Hepatology 12:1350-7, 1990.
18. Pikul J, Sharpe M, Loundes R, Ghent C: Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation 57:469-72, 1993.
19. Calne RY: Contraindications to liver transplantation. Hepatology 20:3S-4S, 1994.
20. Shapiro J, Smith H, Schaffner F: Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 20:137-40, 1979.
21. Poupon R, Balkau B, Guechot J, Heintzman F: Predictive factors in ursodeoxycholic acid treated patients with primary biliary cirrhosis. Hepatology 19:635-40, 1994.
22. Neuberger J, Altmann D, Poison R, et al. Prognosis after liver transplantation for primary biliary cirrhosis. Transplantation 48:444-7, 1989.
23. Keiding S, Ericzon B, Eriksson A, et al: Survival after transplantation of patients with primary biliary cirrhosis in Nordic countries. Scand J Gastroenterol 25:11-8, 1990.
24. Melia W, Johnson P, Neuberger J, et al: Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha foetoprotein. Gastroenterology 87:660-3, 1984.
25. Mills P, Boyle P, Quigley E, et al: Primary biliary cirrhosis: an increased incidence of extra-hepatic malignancies? J Clin Pathol 35:541-3, 1982.
26. Wolke A, Schaffner F, Kapelman B, Sacks H. Malignancy in primary biliary cirrhosis: high incidence of breast cancer in affected women. Am J Med 76:1075-8, 1984.
27. Wiesner R, Porayko M, Dickson ER: Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 16:1290-9, 1992.
28. Gunson B, Buckels J, Elias E, et al: Transplantation for primary biliary cirrhosis. Transplant Proc 22:1503-4, 1990.
29. Markus B, Dickson ER, Grambsch P, et al: Efficacy of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 320:1709-13, 1989.
30. Bonsel G, Klompmaker I, van de Veer F, et al: Use of prognostic models for assessment of value of liver transplantation in primary biliary cirrhosis. Lancet 335:493-7, 1990.
31. Neuberger J, Gunson B, Buckels J, et al: Referral of patients with primary biliary cirrhosis for liver transplantation. Gut 21: 1069-72, 1990.
32. Candinas D, Gunson B, Nightingale P, et al: Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 346: 1117-21, 1995.
33. Oguma S, Belle S, Starzl T, Demetris A: A histometric analysis of chronically rejected liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischaemic factors. Hepatology 9:204-9, 1989
34. Wiesner R, Ludwig J, van Hoek B, Krom R: Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology 14:723-9, 1991.
35. Farges O, Saliba F, Farhamant H, et al: Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology 23:240-8, 1996.
36. Hunt CM, Tart J, Dowdy E, et al: Effect of orthotopic liver transplantation on employment and health status. Liver Transplant Surg 2:148-53, 1996.
37. Adams PC, Ghent C, Grant D, Wall W: Employment after liver transplantation. Hepatology 21:140-4, 1995.
38. Neuberger J, Portmann B, MacDougall B, et al: Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 306:1-4, 1982.
39. Poison R, Portmann B, Neuberger J, et al: Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Gastroenterology 97:715-25, 1989.
40. Lerut J, Zimmerman A, Geretsch P, et al: Chronic rejection and extra-hepatic biliary obstruction 8 years after liver transplantation with gall bladder conduit. HPB Surg 5:17-22, 1991.
41. Hubscher S, Elias E, Buckels J, et al: Primary biliary cirrhosis: histological evidence of disease recurrence after liver transplantation. J Hepatol 18:173-84, 1993.
42. Balan V, Batts K, Porayko M, et al: Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology 18:1392-8, 1993.
43. Ferrell LD, Lee R, Brixko C, et al: Hepatic granulomas following liver transplantation. Transplantation 60:926-30, 1995.
44. Fennell RH, Shikes RH, Vierling JM: Relationship of pre-transplant hepatobiliary disease to bile duct damage occurring in the allograft. Hepatology 3:84-9, 1983.
45. Demetris A, Markus B, Esquivel C, et al: Pathologic analysis of liver transplantation for primary biliary cirrhosis. Hepatology 8:939-47, 1988.
46. Esquivel C, van Thiel D, Demetris A, et al: Transplantation for primary biliary cirrhosis. Gastroenterology 94:1207-16, 1988.
47. Gouw A, Haagsma E, Manns M, et al: Is there recurrence of primary biliary cirrhosis after liver transplantation? J Hepatol 20: 500-7, 1994.
48. Samuel D, Gugenheim J, Mehta G: Liver transplantation for primary biliary cirrhosis. Transplant Proc 22:497-8, 1990.
49. Hart J, Busuttil R, Lewin K: Disease recurrence following liver transplantation. Am J Surg Pathol 14:79-91, 1990.
50. Wong P, Portmann B, O'Grady J, et al: Recurrence of primary biliary cirrhosis after liver transplantation following FK 506-based immunosuppression. J Hepatol 17:284-7, 1993.
51. Dmitrewski J, Hubscher S, Mayer A, Neuberger J: Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression. J Hepatol 24:253-7, 1996.
52. Klein R, Huizenga J, Gips C, Berg PA: Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titers of antimitochondrial antibody subtypes after liver transplantation. J Hepatol 20: 787-9, 1994.
53. Dubel L, Georges O, Bismuth H, et al: Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis. J Hepatol 23:674-81, 1995.
54. Joplin R, Lindsay JG, Johnson G, et al: Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis. Lancet 339:93-4, 1992.
55. Tsuneyama K, van der Water J, Leung PSC, et al: Abnormal expression of PDC-E2 on the luminal surface of biliary epithelial cells occurs before MHC class II and BB1/B7 expression. Hepatology 21:1031-7, 1995.
56. Neuberger J, Wallace L, Joplin R, Hubscher S: Hepatic distribution of E2 component of pyruvate dehydrogenase complex after transplantation. Hepatology 22:798-801, 1995.